GoodRx Holdings, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $796.9 | $792.3 | $750.3 | $766.6 | $745.4 |
| Operating income | $87.5 | $65.8 | -$27.0 | $1.7 | $13.4 |
| Net income | $30.4 | $16.4 | -$8.9 | -$32.8 | -$25.3 |
| Cash Flow Statement | |||||
| Free cash flow | $164.4 | $182.7 | $137.2 | $142.8 | $174.2 |
| Share repurchases | $216.4 | $158.8 | $104.0 | $101.7 | $0.0 |
Shares outstanding 341.1M · Free float 12.6%
Annual filing data through FY ended December 31, 2025; float as of September 13, 2026.